Nanoparticulate Oral Vaccines - An Update

Authors

  • Remya Madan Gopal  Asst. Professor. Pillai HOC College of Arts, Science & Commerce, Rasayani, Navi Mumbai, Maharashtra, India
  • Prashant C. K.  Asst. Professor. Pillai College of Arts, Commerce & Science, New Panvel, Navi Mumbai, Maharashtra, India

Keywords:

Oral Vaccines, Nanoparticles, Particulate Antigens.

Abstract

Being non-invasive in nature, painless and safe, oral delivery of antigens for vaccination is an attractive route of immunization. Oral delivery of vaccines is also a cost-effective strategy. But to escape the acidic environment of the stomach, antigens need to be suitably encapsulated to protect them from rapid degradation. By changing soluble antigens to nanoparticulate forms, it is now realised that better effective oral vaccines may be in the pipeline.

References

  1. Strategies for Developing Oral Vaccines for Human Papillomavirus (HPV) Induced Cancer using Nanoparticle mediated Delivery System. Uddin MN, Kouzi SA, Hussain MD. J Pharm Pharm Sci. 2015 Apr-Jun;18(2):220-34.
  2. Homogeneous PLGA-lipid nanoparticle as a promising oral vaccine delivery system for ovalbumin. Tongtong Ma, Lianyan Wang, Tingyuan Yang, Guanghui Ma, Siling Wang Asian Journal of Pharmaceutical Sciences2014 9(3):129?136
  3. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid. A F. Sarti, G. Perera, F. Hintzen, et al.?? Biomaterials. 2011 32(16):4052?4057
  4. Vaccination: oral vaccine induces genitorectal immunity E. Hutchinson Nat Rev Drug Discov. 2012 11(9):673?673
  5. Fabrication of nanoadjuvant with poly-e-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity.Prashant CK, Bhat M, Srivastava SK, Saxena A, Kumar M, Singh A, Samim M, Ahmad FJ, Dinda AK. Int J Nanomedicine. 2014 9:937-50.
  6. Berzofsky, J. A.; Ahlers, J. D.; Janik, J.; Morris, J.; Oh, S.; Terabe, M.; Belyakov, I. M.Progress on new vaccine strategies against chronic viral infections. JCI 2004, 114, (4), 450- 462
  7. Novel nanocarrier for oral Hepatitis B vaccine. Dinda AK, Bhat M, Srivastava S, Kottarath SK, Prashant CK.Vaccine. 2016 Jun 8;34(27):3076-3081.
  8. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles.Hillyer JF1, Albrecht RM.J Pharm Sci. 2001 Dec;90(12):1927-36.
  9. Oral delivery of particulate prostate cancer vaccine: in vitro and in vivo evaluation.Akalkotkar A, Tawde SA, Chablani L, D'Souza MJ. J Drug Target. 2012 20(4):338-46
  10. Formulation and evaluation of oral microparticulate ovarian cancer vaccines.Tawde SA, Chablani L, Akalkotkar A, D'Souza C, Chiriva-Internati M, Selvaraj P, D'Souza MJ. Vaccine. 2012 30(38):5675-81.
  11. Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review.Islam MA, Firdous J, Choi YJ, Yun CH, Cho CS.Int J Nanomedicine. 2012;7:6077-93.
  12. Bilosomes in the context of oral immunization: development, challenges and opportunities.Shukla A, Mishra V, Kesharwani P. Drug Discov Today. 2016 21(6):888-99.
  13. Enteric trimethyl chitosan nanoparticles containing hepatitis B surface antigen for oral delivery.Farhadian A, Dounighi NM, Avadi M.Hum Vaccin Immunother. 2015;11(12):2811-8.
  14. Immunogenicity and protection of oral influenza vaccines formulated into microparticles.Shastri PN, Kim MC, Quan FS, D'Souza MJ, Kang SM. J Pharm Sci. 2012 101(10):3623-35.

International Journal of Scientific Research in Science and Technology

Downloads

Published

2018-03-10

Issue

Volume 4, Issue 4, March-April-2018

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Remya Madan Gopal, Prashant C. K., " Nanoparticulate Oral Vaccines - An Update, International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 4, Issue 4, pp.30-33, March-April-2018.